Regulatory concerns at various phases of drug development

被引:3
作者
Aurecchia, S
Orloff, D
Sobel, S
机构
[1] US Food & Drug Adm, Ctr Drug Evaluat & Res, Rockville, MD USA
[2] US FDA, Ctr Drug Evaluat & Res, Rockville, MD 20857 USA
关键词
D O I
10.1016/S0002-9149(98)00250-1
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:2F / 4F
页数:3
相关论文
共 8 条
  • [1] 1993, GUIDELINE STUDY EVAL
  • [2] 1994, INT C HARM E7 AUG
  • [3] 1995, INT C HARM E1A MAR
  • [4] 1997, INT C HARM M3 MAY
  • [5] 1997, INT C HARM S2B APR
  • [6] 1994, INT C HARM E4 NOV
  • [7] 1995, INT C HARM S1A NOV
  • [8] 1993, INT HARM S5A JUN